Skip to main content
. 2010 Apr 15;6(2):131–137.

Table 4.

Percentage of patients with AHI > 10 by subgroups

Dimension Group # Studies % AHI > 10 (95% CI) p-value
Overall All Studies 23 62 (57–67)

Event type Ischemic Stroke 3 61 (42–78) 0.489
TIA 3 52 (30–73)
Hemorrhagic Stroke 4 71 (50–85)

Prior event First 9 57 (49–64) 0.013
Recurrent 3 74( 63–82)

Sex Female 12 48 (40–56) 0.001
Male 12 65 (59–71)

Patient location Cohort 1 45 (34–56) 0.009
Rehab Unit 4 57 (45–68)
Inpatient Unit 18 64 (58–69)

Timing of study after CVA < 7 days 13 60 (55–65) 0.128
7-28 days 7 72 (60–81)
> 28 days 3 53(37–69)

Stroke etiology Cardioembolic 3 48 (41–56) 0.005
Macrovascular 3 71 (49–86)
Microvascular 3 61 (46–74)
Other 3 66 (31–90)
Unknown 3 82 (66–91)

Study type Full PSG (with EEG) 8 63 (54–71) 0.226
Limited (without EEG) 11 58 (51–64)
AutoCPAP 4 75 (54–88)

Testing method Pressure Transducer 8 58 (50–66) 0.319
Thermistor 10 59 (53–66)
Auto-CPAP 4 75 (54–88)

Hypopnea criteria Arousal or desat with reduced flow 5 58 (48–68) 0.860
Desaturation with reduced flow 5 63 (51–75)
Effort reduction 4 63 (50–74)
Flow reduction alone 6 67 (52–79)
Flow-50 2 60 (49–70)

CI, confidence interval. The p-values indicate whether any of the subgroups had a statistical effect on the percentage of patients with AHI > 10 determined with a random effects model.Hypopnea criteria: Flow-50, flow reduction at least 50% or flow reduction at least 30% with desaturation or arousal (if full PSG).